The University of North Carolina at Chapel Hill is committed to combatting Human Trafficking. Federal law mandates that federal contractors and subcontractors maintain an anti-trafficking compliance program to qualify for certain federal funds and grants. This policy establishes a compliance plan and reporting requirements that meet federal standards.
This Policy is meant to describe how the University of North Carolina at Chapel Hill manages Research Administrative Data for certain types of Clinical Research studies.
This Standard is meant to provide the minimum expectations for users of the University of North Carolina at Chapel Hill’s Data Management System (“DMS”) for Clinical Research Administrative Data. This Standard is intended to further the University’s goals of providing DMS users with efficient and accurate administrative data and to promote legal and regulatory compliance.
This document establishes a uniform policy for billing of procedures, items, or tests provided to participants who participate in clinical research studies to ensure compliance with federal, state, and institutional guidelines. This policy supplements existing policies related to the conduct of clinical research studies. This policy is applicable to medical items or services provided as part of a clinical research study; however, it does not apply to studies that do not involve human subjects.
This policy establishes the University of North Carolina at Chapel Hill ownership of Research Data. The University is obligated, by federal funding agency grant terms, federal and state regulations, policies, other contractual terms, and its mission statement, to ensure that research data and materials are secured and appropriately accessible.
The University of North Carolina at Chapel Hill values and supports entrepreneurial activity by faculty. Faculty use of university resources in support of appropriate entrepreneurial activities may be allowed provided these activities do not conflict with applicable policies regarding use of public facilities for private gain. Incidental and minimal use of office, library, machine shop, personal desktop work stations, storage servers, communication devices, or clerical staff is permitted.
This procedure describes the process for requesting human pharmaceutical agents from UNC Health Shared Services Center (SSC) Pharmacy for use in animal and in-vitro laboratory research conducted and supported by the University of North Carolina at Chapel Hill.
The University of North Carolina at Chapel Hill, as one of the leading public research universities in the nation, is committed to maintaining the integrity and validity of the academic research conducted by faculty, staff and students. The guiding principles and standards set forth in this policy are in alignment with the University's goal to continually improve and to maintain its status as a world-class research university attracting the best faculty, staff and students.
This document sets forth the standards of research conduct expected of members of the research community at The University of North Carolina at Chapel Hill, consistent with the Research Code of Conduct Policy.
Public trust in the integrity and ethical behavior of scholars must be maintained if research is to continue to play its proper role in our University and society. While the primary responsibility for maintaining integrity in research rests with those who conduct it, the University has established standards to ensure a healthy environment for research and compliance with law.
This procedure explains how the University responds to allegations of Research Misconduct.
This document provides guidance to faculty and administrators on activities allowed under the University of North Carolina at Chapel Hill Policy on Use of University Resources in Support of Entrepreneurial Activities. However, deans, chairs, directors and supervisors must ultimately determine how their units' resources are utilized consistent with State and University policy.
The University of North Carolina at Chapel Hill ("University") recognizes the potential value of Human Embryonic Stem Cells in research, including clinical research. The University encourages their responsible use as a means of advancing knowledge, with the eventual goal of using these cells in therapeutic practice in hopes of curing disease and ameliorating other disabling or debilitating health conditions.
The policy establishes the requirements for using University-approved electronic research systems to obtain legally valid electronic signatures on essential documents for clinical research at the University of North Carolina at Chapel Hill (“University” or “UNC-Chapel Hill”). Its purpose is to ensure regulatory compliance, enhance efficiency, and improve oversight of electronic signatures in clinical research.